FDA to Hold Listening Session as Part of Broader Work to Optimize Use of, and Processes for, Advisory Committees
FDA will host a listening session in June as part of broader work to optimize the use of, and processes, for advisory committees.
FDA will host a listening session in June as part of broader work to optimize the use of, and processes, for advisory committees.
OCE experts regularly join colleagues to participate in major conferences.
Congenital syphilis has risen significantly in the United States. The Times would like to talk to women who experienced the condition when pregnant and learn…
New research shows the “upside-down trees” originated in Madagascar and then caught a ride on ocean currents to reach mainland Africa and Australia.
AstraZeneca said that a new long-acting antibody reduced immunocompromised patients’ risks of contracting symptomatic Covid-19 infections in a large Phase 3 prevention trial. Still, it’s…
Videos filmed by divers show that choking, blinding and sacrificing limbs are all in the cephalopods’ repertoire.
Artificial intelligence and obesity-focused startups completed funding deals this week.
Por lo general, la presión arterial alta no da síntomas, pero puede ocasionar condiciones que ponen en riesgo la vida como ataque al corazón o…
bladder cancer, Circulating Tumor DNA (ctDNA), Residual Disease Detection, imvigor010 study, immunotherapy, adjuvant therapy, urine tumor DNA markers, treatment of invasive bladder cancer.
On May 16, 2024, the FDA granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen, Inc.) for extensive stage small cell lung cancer.
The European Medicines Agency (EMA) on Friday recommended scrapping approval for a drug used to prolong gestation, citing a “possible but unconfirmed” risk of cancer.